The ultrasound of the first trimester allows to determinate the pregnancy beginning, the type of pregnancy and also to detect increased nuchal translucency (NT). Fetuses with common chromosomal abnormalities (trisomies 21, 18 and 13 and monosomy X) and structural abnormalities (particularly cardiac defects) and single-gene disorders frequently show increased NT. The purpose of this study is to evaluate in the population of Limousin, the type and frequency of these abnormalities.
Increased NT superior than 95th percentile (Nicolaides curves) during the ultrasound of the first trimester, are associated to common chromosomal abnormalities. It's therefore necessary to make amniocentesis and to analyze karyotyping and Genomic microarrays, also known as chromosomal microarrays (CMA). In euploid foetus, increased NT is also associated with structural defects or genetic syndromes. Additionally, the overall long-term growth of euploid children with increased NT is not much known. The majority (98%) of euploid children with a normal second trimester ultrasound is apparently healthy in the short run. The investigator's objective is to evaluate in a retrospective way, different events (structural defects, chromosomal or genetic abnormalities) during these pregnancies. In a prospective way, the neurodevelopmental disorders in euploid children will be investigated.
Study Type
OBSERVATIONAL
Enrollment
392
There will be a first part with a retrospective study in order to collect pregnancy data to answer to the primary endpoint. Then, there will be a prospective part where mothers and their children will have to answer an evaluation survey.
CHU de Limoges
Limoges, France
Number of chromosomal abnormalities on fetuses with increased nuchal translucency
Characterization of fetuses with increased nuchal translucency by Identification of chromosomal abnormalities, structural defects and genetic syndromes on fetuses with increased nuchal translucency
Time frame: 6 months
Number structural defects on fetuses with increased nuchal translucency
Characterization of fetuses with increased nuchal translucency by Identification of chromosomal abnormalities, structural defects and genetic syndromes on fetuses with increased nuchal translucency
Time frame: 6 months
Number of genetic syndromes on fetuses with increased nuchal translucency
Characterization of fetuses with increased nuchal translucency by Identification of chromosomal abnormalities, structural defects and genetic syndromes on fetuses with increased nuchal translucency
Time frame: 6 months
Rate of each Pregnancy outcomes
Numbers of alive children, fetal death in utero, abortions on medical grounds, stillborn, children born prematurely
Time frame: 1 year
structural defects
Numbers and type term of structural defects
Time frame: 1 year
maternofetal infection
number and type of maternofetal infection
Time frame: 1 year
postnatal structural defects
Numbers and type of postnatal structural defects
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
postnatal chromosomal abnormalities
Number and type of postnatal chromosomal abnormalities
Time frame: 1 year
postnatal genetic syndromes
Number and type of postnatal genetic syndromes
Time frame: 1 year
Determination of a neck thickness threshold at risk of psychomotor developmental delay
Neurodevelopmental evaluation score of Age Stage Questionnaire ASQ-3 (for 2 months, 9 months, 1 year, 2 years, 3 years, 4 years and 5 years children) or Global School Adaptation GSA (from 6 to 8 years children).
Time frame: 1 year
Determination of a neck thickness threshold at risk of malformations and requiring the persistence of monthly ultrasound monitoring
Numbers and type of postnatal structural defects
Time frame: 1 year
Study of the psychomotor development of nuchal translucency with normal genetic analysis
Neurodevelopmental evaluation score of Age Stage Questionnaire (ASQ-3) (for 2 months, 9 months, 1 year, 2 years, 3 years, 4 years and 5 years children without genetic abnormalities) or Global School Adaptation (GSA) (from 6 to 8 years children without genetic abnormalities).
Time frame: 1 year